Page last updated: 2024-10-25

deferoxamine and Femoral Fractures

deferoxamine has been researched along with Femoral Fractures in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Femoral Fractures: Fractures of the femur.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shen, X1
Wan, C1
Ramaswamy, G1
Mavalli, M1
Wang, Y1
Duvall, CL1
Deng, LF1
Guldberg, RE1
Eberhart, A1
Clemens, TL1
Gilbert, SR1
Stewart, R1
Goldstein, J1
Eberhardt, A1
Chu, GT1
Gilbert, S1

Other Studies

2 other studies available for deferoxamine and Femoral Fractures

ArticleYear
Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2009, Volume: 27, Issue:10

    Topics: Amino Acids, Dicarboxylic; Animals; Bony Callus; Cell Proliferation; Deferoxamine; Endothelium, Vasc

2009
Increasing vascularity to improve healing of a segmental defect of the rat femur.
    Journal of orthopaedic trauma, 2011, Volume: 25, Issue:8

    Topics: Angiogenesis Inducing Agents; Animals; Bone Morphogenetic Protein 2; Deferoxamine; Dose-Response Rel

2011